HSP47 protein study in blood clots
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at a protein called HSP47 in people with blood clots, heart attacks, or strokes caused by atrial fibrillation, compared to healthy volunteers. It aims to learn more about how blood clots form and may lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Willing and able to give informed consent
- For the blood clot group: deep vein clot confirmed by ultrasound or lung clot confirmed by CT scan
- For the heart attack group: specific heart changes on EKG and a blocked artery seen on angiogram
- For the stroke group: stroke seen on MRI along with a heart rhythm problem called atrial fibrillation
- For the healthy group: no known medical conditions and no prior blood clot, heart attack, or stroke
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain blood cell changes and immune system activity may relate to blood clots in specific veins or lungs. It may help researchers understand why clots happen “without a clear cause” and how to better predict risk.
This study looks at blood and clot samples from people who have had a stroke to understand how inflammatory cells behave. It may help doctors learn more about why strokes happen and improve treatments in the future.
This trial aims to learn more about blood clots, inflammation, and blood vessel problems. It may help researchers better understand these conditions and how they affect people.
This study looks at the blood clots removed from the brain during a procedure called thrombectomy. By studying them, researchers hope to learn more about how to treat strokes and what causes them, which could help improve care.
This study looks at how certain proteins in the blood change after a procedure to remove a large blockage in a brain artery. The goal is to better understand recovery after stroke treatment.
This study collects and stores medical information and biological samples from people with atrial fibrillation (or certain types of stroke). It helps researchers better understand these conditions and may support future improvements in diagnosis or treatment.
Hear when a new Venous Thromboembolism (VTE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.